Department of Research Pathology, Genentech, Inc., South San Francisco, California.
J Histochem Cytochem. 2019 May;67(5):309-334. doi: 10.1369/0022155419832002. Epub 2019 Mar 18.
Optimization and standardization of immunohistochemistry (IHC) protocols within and between laboratories requires reproducible positive and negative control samples. In many situations, suitable tissue or cell line controls are not available. We demonstrate here a method to incorporate target antigens into synthetic protein gels that can serve as IHC controls. The method can use peptides, protein domains, or whole proteins as antigens, and is compatible with a variety of fixation protocols. The resulting gels can be used to create tissue microarrays (TMAs) with a range of antigen concentrations that can be used to objectively quantify and calibrate chromogenic, fluorescent, or mass spectrometry-based IHC protocols. The method offers an opportunity to objectively quantify IHC staining results, and to optimize and standardize IHC protocols within and between laboratories. (J Histochem Cytochem 58:XXX-XXX, 2019).
在实验室内部和实验室之间优化和标准化免疫组织化学(IHC)方案需要可重复的阳性和阴性对照样本。在许多情况下,没有合适的组织或细胞系对照。我们在此展示一种将靶抗原掺入合成蛋白凝胶中的方法,该凝胶可作为 IHC 对照。该方法可以使用肽、蛋白结构域或整个蛋白作为抗原,并且与多种固定方案兼容。由此产生的凝胶可用于创建具有一系列抗原浓度的组织微阵列(TMA),可用于客观地定量和校准基于显色、荧光或质谱的 IHC 方案。该方法为客观地定量 IHC 染色结果,并在实验室内部和实验室之间优化和标准化 IHC 方案提供了机会。(J Histochem Cytochem 58:XXX-XXX, 2019)。